To test the hypothesis that Aβ aggregation can itself lead to declines in large-scale brain connectivity, metabolism, and cognitive function, we conducted a longitudinal, multimodal biomarker study using the McGill-R-Thy1-APP Tg rat model of AD-like Aβ pathology, which expresses hAPP with Swedish and Indiana mutations. This evidence concerns the gene THY1 and Alzheimer disease.